Sign in to view Dmitry’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Sign in to view Dmitry’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
United Kingdom
Sign in to view Dmitry’s full profile
Dmitry can introduce you to 10+ people at Deep Knowledge Group
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
23K followers
500+ connections
Sign in to view Dmitry’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with Dmitry
Dmitry can introduce you to 10+ people at Deep Knowledge Group
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
View mutual connections with Dmitry
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Sign in to view Dmitry’s full profile
or
New to LinkedIn? Join now
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Websites
- Personal Website
-
https://www.kaminskiy.info
- Company Website
-
https://www.dkv.global
About
Welcome back
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
Articles by Dmitry
-
The Longevity Industry will be the Biggest but also Most Complex Industry in Human History
The Longevity Industry will be the Biggest but also Most Complex Industry in Human History
The Longevity industry will dwarf all other industries in both size and market capitalization but also will require…
69
6 Comments -
Specialized Metrics for Assessment of AI-Pharma StartupsApr 15, 2019
Specialized Metrics for Assessment of AI-Pharma Startups
This is a general description of the project that we were working on during 2018 which will get further implementation…
27
2 Comments -
DeepTech: Where Advanced Engineering Meets Deep ScienceJan 22, 2019
DeepTech: Where Advanced Engineering Meets Deep Science
This is the first article in a weekly series on DeepTech that I'm writing with Margaretta Colangelo. Our DeepTech…
27
-
AI at the Forefront of BioChemistry: BioPharma must innovate or dieDec 8, 2018
AI at the Forefront of BioChemistry: BioPharma must innovate or die
Although pharmaceutical companies spend over $172 billion on research and development annually, over 90% of molecules…
14
-
“FinTech for Social Good” Analytical Report, Special EditionAug 20, 2018
“FinTech for Social Good” Analytical Report, Special Edition
Deep Knowledge Analytics, the analytical arm of Deep Knowledge Ventures, in coordination with Future FinTech announces…
20
-
Key Points of the Most Comprehensive 640-page Analytical Report on the State of “AI for Drug Discovery Industry Q2 2018”Aug 7, 2018
Key Points of the Most Comprehensive 640-page Analytical Report on the State of “AI for Drug Discovery Industry Q2 2018”
Deep Knowledge Analytics published most comprehensive industry analytical report to date: AI for Drug Discovery…
20
2 Comments -
Most Comprehensive 640-page Analytical Report on State of “AI for Drug Discovery Industry Q2 2018”Aug 2, 2018
Most Comprehensive 640-page Analytical Report on State of “AI for Drug Discovery Industry Q2 2018”
Deep Knowledge Analytics is pleased to announce the publication of its most advanced industry analytical report to…
29
1 Comment -
845-page Longevity Industry in UK Landscape Overview 2018Jul 30, 2018
845-page Longevity Industry in UK Landscape Overview 2018
Deep Knowledge Analytics announces the publication of a new analytical report titled Longevity Industry in UK Landscape…
14
-
Deep Knowledge Ventures Salutes Insilico Medicine on Close of Latest Financing RoundJun 11, 2018
Deep Knowledge Ventures Salutes Insilico Medicine on Close of Latest Financing Round
Deep Knowledge Ventures Salutes Insilico Medicine on Close of Latest Financing Round http://analytics.dkv.
15
-
Most Advanced Analytical Report on AI for Drug Discovery to Date /(Q1 2018)The State of AI for Drug Discovery, Biomarker Development and Advanced R&DMay 28, 2018
Most Advanced Analytical Report on AI for Drug Discovery to Date /(Q1 2018)The State of AI for Drug Discovery, Biomarker Development and Advanced R&D
Deep Knowledge Analytics released one of its most advanced analytical report on the subject of AI for Drug Discovery…
26
Activity
23K followers
-
Dmitry Kaminskiy reposted thisDmitry Kaminskiy reposted thisHong Kong Chief Executive John Lee, head of the city's government, has referenced our Global AI Competitiveness Index report series in his opening speech for the World Internet Conference Asia-Pacific Summit Mr. Lee pointed to Hong Kong’s standing in AI preparedness and its #3 position in the Global AI Competitiveness Index (AI-GCI), after New York and London. As report host and analytics provider within the AI-GCI Consortium, Deep Knowledge Group is gratified that the index continues to be used as a reference point in high-level discussions of Hong Kong’s AI development agenda. See full coverage of the speech at CGTN: https://lnkd.in/d_w_FhDm Access all six thematic editions of the Global AI Competitiveness Index, now in its third year of publication, here: https://lnkd.in/eatEGXtx. Dame Jenny Shipley, King Au, Prof. Dr. Patrick Glauner, Rudolf Scharping, Rudolf Mellinghoff, Christophe Schommer, Prof. Dr. Volker Römermann, CSP, Dmitry Kaminskiy
-
Dmitry Kaminskiy reposted thisDmitry Kaminskiy reposted thisHong Kong Chief Executive Lee cited our report 🇭🇰📘 On Monday, Hong Kong Chief Executive John Lee spoke at the World Internet Conference Asia-Pacific Summit and referred to our series of Global AI Competitiveness Index reports: "Hong Kong ranks among the world's leading economies in AI preparedness [...] Meanwhile, Hong Kong came third in the Global AI Competitiveness Index, after only New York and London." I couldn't be more happy about this recognition of our reports jointly written by Dmitry Kaminskiy, his team at Deep Knowledge Group and me for the last 1.5 years. Read the full article in Radio Television Hong Kong (RTHK) here: https://lnkd.in/gZAcZFtU Find all reports here: https://lnkd.in/gJwvfqD8 Many thanks also go to our advisors, collaborators supporters Joseph HL Chan, Rocky Tung, Dame Jenny Shipley, Rudolf Scharping, Rudolf Mellinghoff, King Au, Christophe Schommer, Prof. Dr. Volker Römermann, CSP, Franco Cortese, Xin Zhou, Jian Zhou, Joyce Lee, Financial Services Development Council and many others.
-
Dmitry Kaminskiy reposted thisDmitry Kaminskiy reposted this“Hong Kong ranks among the world's leading economies in AI preparedness… Meanwhile, Hong Kong came third in the Global AI Competitiveness Index, after only New York and London.” At the World Internet Conference Asia-Pacific Summit, Hong Kong’s Chief Executive John Lee, head of the Hong Kong Government 香港政府, highlighted Hong Kong’s growing AI position. The Global AI Competitiveness Index cited in the speech is part of the analytical report series produced by the Global AI Competitiveness Index Consortium and hosted by Deep Knowledge Group. Parts 4 and 5 of the AI Index were released in previous months, with the Hong Kong Financial Services Development Council serving as Report Observer, and the upcoming Part 6 will extend the benchmark into AI in biotechnology, healthcare and longevity. Hong Kong’s compute capacity, Hetao Shenzhen-Hong Kong Science and Technology Innovation Co-operation Zone, and Greater Bay Area integration are becoming central to its AI competitiveness story. And the intersection of Hong Kong’s status as a leading financial hub with its increasingly prominent AI competitiveness creates a self-inducing cycle of reinforcement. Read the full article in Radio Television Hong Kong (RTHK) here: https://lnkd.in/d9chh4f3 #ArtificialIntelligence #HongKong #Innovation #Technology #AICompetitiveness #GreaterBayArea #DigitalEconomy Joseph HL Chan, Rocky Tung, Dame Jenny Shipley, Rudolf Scharping, Rudolf Mellinghoff, King Au, Prof. Dr. Patrick Glauner, Christophe Schommer, Prof. Dr. Volker Römermann, CSP, Dmitry KaminskiyHK ready to become international I&T hub: CE - RTHKHK ready to become international I&T hub: CE - RTHK
-
Dmitry Kaminskiy reposted thisDmitry Kaminskiy reposted this𝐆𝐮𝐥𝐟 𝐍𝐞𝐰𝐬 𝐏𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐬 𝐂𝐨𝐦𝐦𝐞𝐧𝐭𝐚𝐫𝐲 𝐛𝐲 𝐃𝐦𝐢𝐭𝐫𝐲 𝐊𝐚𝐦𝐢𝐧𝐬𝐤𝐢𝐲 𝐨𝐧 𝐖𝐚𝐫 𝐀𝐧𝐱𝐢𝐞𝐭𝐲 𝐚𝐧𝐝 𝐋𝐨𝐧𝐠𝐞𝐯𝐢𝐭𝐲 𝐇𝐞𝐚𝐥𝐭𝐡 An opinion article authored by Dmitry Kaminskiy, General Partner at Deep Knowledge Group, has been published by Gulf News, examining the concept of “war anxiety” through the lens of longevity medicine. The article advances the argument that prolonged exposure to conflict-related stress—particularly through continuous digital media consumption—constitutes not only a psychological burden but also a significant biological risk factor, contributing to accelerated ageing and increased susceptibility to chronic disease. Kaminskiy outlines a structured framework of behavioural interventions aimed at mitigating these effects, including the regulation of information intake, the establishment of daily routines, the prioritisation of social connectedness, and the integration of physical activity. The analysis further emphasises the importance of emotional regulation and timely access to professional support where necessary. From a strategic perspective, the commentary positions stress management as a core component of preventive health and longevity strategy, highlighting the growing relevance of resilience-building practices in environments characterised by sustained geopolitical uncertainty. Read full article here: https://lnkd.in/dsBwSaYb
-
Dmitry Kaminskiy reposted thisDmitry Kaminskiy reposted thisPart 2. UAE Labour Law has a blind spot. And thousands of stranded employees are sitting right in the middle of it. Federal Decree-Law No. 33 of 2021 was a major upgrade. But it was written for normal times. It has no force majeure provision for employment relationships. When airspace shuts down and your employee can't return - the law doesn't tell you what happens to their salary. Paid or unpaid? Who bears the cost? No answer. What fills the gap? General principles. Good faith. Case-by-case assessment. In legal terms - uncertainty. During COVID, the government stepped in. Ministerial Resolution No. 279 of 2020 introduced temporary measures - salary reductions, unpaid leave frameworks, adjusted termination rules. It wasn't perfect, but it was clear. This time? No MOHRE circular. No temporary legislation. Nothing. Possibly because the 2022 reforms gave employers enough flexibility. Possibly because remote work is common enough. But for the employee who can't work remotely: the warehouse worker, the site engineer, the retail manager - that logic doesn't apply. This is where it gets legally dangerous: Article 44 allows termination for 7+ days of absence without valid reason. Force majeure absences shouldn't qualify, but the law doesn't explicitly say so. An aggressive employer could try. Most UAE employment contracts signed before 2022 contain force majeure clauses lifted from commercial agreements. Designed for supply chain disputes, not employment. They reference "suspension of obligations" without defining what that means for salary, leave accrual, or end-of-service. The WPS adds another layer. Stop paying without updating WPS and you're in breach. Update WPS to reflect zero salary - you've just created a documented record of non-payment that strengthens the employee's future claim. In practice, outcomes depend entirely on your employer's goodwill. Two people in identical situations can face completely different outcomes. That's a lottery, not a legal framework. The UAE needs a codified force majeure framework for employment - one that defines salary obligations during government-imposed disruptions and protects employees from termination for circumstances they cannot control. The system isn't broken. But those most affected by the gap are those with the least power to negotiate around it. #UAELabourLaw #ForceMajeure #EmployeeRights #LegalReform #LegalinePlatform #GulfBusiness
-
Dmitry Kaminskiy reposted thisDmitry Kaminskiy reposted thisThousands of UAE employees are stranded abroad right now. Airspace closures. Flight cancellations. No clear return date. And the question everyone is asking their HR department: "Do I still get paid?" Here's the uncomfortable truth: UAE Labour Law doesn't have a direct answer. Federal Decree-Law No. 33 of 2021 has no specific provision for employees stranded due to airspace closures or regional conflict. There's no force majeure clause that neatly solves this. Instead, it falls into a grey zone governed by general principles of good faith, legitimate absence, and the employer's duty to act reasonably. What does that actually mean in practice? I broke it down in my latest piece for Gulf Business covering salary rights, employer obligations, and what both sides should be doing right now. #UAELabourLaw #ForceMajeure #EmploymentLaw #UAE #HR #LegalinePlatform #GulfBusiness
-
Dmitry Kaminskiy reposted thisDmitry Kaminskiy reposted thisMost people only think about contracts when something goes wrong. But during geopolitical crises, contracts quietly become one of the most important structures in the global economy. Supply chains break. Payments are delayed. Sanctions appear. Obligations suddenly become difficult to fulfil. In these moments, contracts determine how risks are distributed between businesses, partners and institutions. I recently shared some thoughts in Gulf Business on how companies and individuals in the UAE can better understand legal risks during periods of global uncertainty. Legal infrastructure is becoming an increasingly important part of how the global economy functions. More thoughts in the article below. https://lnkd.in/evNbyazE
-
Dmitry Kaminskiy reposted thisDmitry Kaminskiy reposted this𝐀𝐫𝐚𝐛 𝐍𝐞𝐰𝐬: 𝐓𝐡𝐞 𝐂𝐚𝐬𝐞 𝐟𝐨𝐫 𝐋𝐨𝐧𝐠𝐞𝐯𝐢𝐭𝐲 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐢𝐧 𝐭𝐡𝐞 𝐆𝐮𝐥𝐟 Arab News has published a new opinion article by Dmitry Kaminskiy, General Partner of Deep Knowledge Group, examining how targeted investment in longevity-focused healthcare could significantly improve life expectancy across GCC countries. The article highlights the region’s unique position to advance longevity science and healthcare innovation, given its access to capital, rapidly modernizing healthcare infrastructure, and strong government-led strategic initiatives. Kaminskiy outlines how allocating 1–2% of GDP toward longevity-oriented healthcare systems — including preventive medicine, advanced diagnostics, and emerging health technologies — could increase life expectancy in the Gulf by 2–4 years over the next two decades. The article also emphasizes the importance of integrating AI-driven diagnostics, precision medicine, preventive healthcare programs, and age-related technologies to improve both lifespan and healthspan. In addition to public health benefits, the analysis highlights the broader economic impact of longevity investment, noting that healthier and longer-living populations can contribute to higher productivity, extended workforce participation, and more resilient healthcare systems. https://lnkd.in/dqR9Cwyg
-
Dmitry Kaminskiy reposted thisDmitry Kaminskiy reposted this𝐀𝐫𝐚𝐛 𝐍𝐞𝐰𝐬 𝐏𝐮𝐛𝐥𝐢𝐬𝐡𝐞𝐬 𝐃𝐦𝐢𝐭𝐫𝐲 𝐊𝐚𝐦𝐢𝐧𝐬𝐤𝐢𝐲 𝐂𝐨𝐦𝐦𝐞𝐧𝐭𝐚𝐫𝐲 𝐨𝐧 𝐋𝐨𝐧𝐠𝐞𝐯𝐢𝐭𝐲 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐢𝐧 𝐭𝐡𝐞 𝐆𝐮𝐥𝐟 Arab News published an opinion article by Dmitry Kaminskiy, General Partner of Deep Knowledge Group, exploring how strategic investment in longevity-focused healthcare could increase life expectancy across GCC countries. The article outlines how allocating 1–2% of GDP to longevity-oriented healthcare systems — including preventive care, advanced medical technologies, and healthier living environments — could raise life expectancy in the region by 2–4 years over the next two decades. The commentary highlights Saudi Arabia and the UAE as well positioned to lead this development due to their expanding healthcare infrastructure and sustained investment in medical innovation. Saudi Arabia’s healthcare transformation under Vision 2030, alongside the UAE’s focus on biotechnology, regenerative medicine, and advanced medical research, is presented as a strong foundation for scaling longevity-focused initiatives. The article concludes that sustained investment in longevity can generate both public health and economic benefits, supporting healthier populations, longer workforce participation, and more resilient healthcare systems across the Gulf. Source: https://lnkd.in/dqR9Cwyg Digital Newspaper: https://lnkd.in/d89YnUyp
-
Dmitry Kaminskiy liked thisDmitry Kaminskiy liked thisI’ve had the wonderful opportunity and privilege of helping build and nurture dozens of companies that successfully went public. Over the years, one thing has become increasingly clear to me: every exceptional founder I’ve worked with shares the same core mission — to develop the best possible therapies and diagnostic tools for patients. Today, I am truly delighted and honored to attend the Nasdaq bell-ringing ceremony for Alamar Biosciences (NASDAQ: ALMR), a global leader in precision proteomics! I led Alamar’s first financing round when the company had only early feasibility data. What convinced me was the founding team’s unwavering determination and dedication to building the world’s top proteomics platform. Today, their products have been validated and adopted by numerous top pharmaceutical and biotechnology companies. Warmest congratulations to Yuling Luo, Steve Chen, Yiyuan Yin and the entire Alamar team! Congratulations on this major milestone! We will continue to support visionary and mission-driven entrepreneurs in healthcare and medical technology. The future of precision medicine has never been more exciting. #PrecisionMedicine #Proteomics #Biotech #AlamarBiosciences #Nasdaq #HealthcareInnovation #LifeSciences #IPO #VentureCapital #Alamar #neuroscience #PrecisionProteomics
-
Dmitry Kaminskiy liked thisDmitry Kaminskiy liked thisI recently had the opportunity to sit down with Scott Carney for a wide-ranging conversation on regenerative medicine, stem cells, peptides, and the growing gap between scientific promise and clinical reality. It’s a topic that sits right at the intersection of hope, hype, and harm. There is real science here. Regenerative medicine—at its core—is about repairing damage and restoring function. That’s a fundamentally valid and exciting approach to improving healthspan. But the reality is more complicated. Much of what’s being marketed today exists far ahead of the evidence. In many cases, we don’t have high-quality data on safety or efficacy. And once you step outside of regulated systems, you introduce an additional layer of risk around manufacturing quality, contamination, and outright fraud. That doesn’t mean people seeking these therapies are irrational. In many cases, they’re dealing with real suffering—and a healthcare system that doesn’t have good answers. The demand is understandable. The problem is the supply. What we’re seeing now is a rapidly expanding marketplace where: • Scientific breakthroughs are overstated • Early-stage findings are marketed as clinical solutions • And financial incentives often outpace scientific integrity At the same time, there’s a deeper systemic issue: For many of these therapies, no one is incentivized to do the clinical trials that would actually give us answers. So we’re left in a strange place: People want access. The science is promising but incomplete. And the infrastructure to evaluate these therapies properly is largely missing. In the conversation, we dig into: – Why stem cell therapies have lagged behind early expectations – What’s real (and not) about newer approaches like MUSE cells – The risks of black market biologics and unregulated peptides – And what a better path forward could look like My view hasn’t changed: We need more data, not more hype. And we need systems that allow responsible access while generating real evidence. That’s the only way this field moves forward. 🎧 Full episode here: https://lnkd.in/g7xTYFUF Curious to hear how others in this space are thinking about this—especially clinicians navigating patient demand vs. evidence.Exposing the Regenerative Medicine Scam: Stem Cells, Peptides, Exosomes, and Fake ScienceExposing the Regenerative Medicine Scam: Stem Cells, Peptides, Exosomes, and Fake Science
-
Dmitry Kaminskiy liked thisDmitry Kaminskiy liked this🏛️ Contributing to Global Dialogue with Members of Parliament on AI and Quantum Computing Today, I briefed the Working Group on Science and Technology (WGST) of the Inter-Parliamentary Union (IPU) on the intersection of AI 🤖 and quantum computing ⚛️. I have argued why quantum computing is first of all an opportunity, not a threat. My presentation was deeply rooted in mathematics and algorithms, yet I made my content more accessibly for that diverse audience. 🌍 The 152nd IPU Assembly is currently taking place in Istanbul 🇹🇷. I have joined online this time due to parallel teaching commitments at Deggendorf Institute of Technology. The IPU was founded in 1889 and is the global organization of national parliaments, bringing together legislators from around the world to strengthen democracy 🏛️, foster dialogue and address global challenges collaboratively. In an increasingly complex and fragmented world, this science-policy interface is more important than ever. I’ve been collaborating regularly with the IPU and truly value the opportunity to advise policymakers - something I genuinely enjoy. Bridging the gap between technological innovation and responsible governance is both a challenge and a responsibility. #IPU152 #AI #QuantumComputing #TechPolicy #ScienceDiplomacy
-
Dmitry Kaminskiy liked thisDmitry Kaminskiy liked thisHong Kong Chief Executive John Lee, head of the city's government, has referenced our Global AI Competitiveness Index report series in his opening speech for the World Internet Conference Asia-Pacific Summit Mr. Lee pointed to Hong Kong’s standing in AI preparedness and its #3 position in the Global AI Competitiveness Index (AI-GCI), after New York and London. As report host and analytics provider within the AI-GCI Consortium, Deep Knowledge Group is gratified that the index continues to be used as a reference point in high-level discussions of Hong Kong’s AI development agenda. See full coverage of the speech at CGTN: https://lnkd.in/d_w_FhDm Access all six thematic editions of the Global AI Competitiveness Index, now in its third year of publication, here: https://lnkd.in/eatEGXtx. Dame Jenny Shipley, King Au, Prof. Dr. Patrick Glauner, Rudolf Scharping, Rudolf Mellinghoff, Christophe Schommer, Prof. Dr. Volker Römermann, CSP, Dmitry Kaminskiy
-
Dmitry Kaminskiy liked thisDmitry Kaminskiy liked this【When the “Building of the Future” Turns Forty: The Story of the HSBC Main Building】 Standing in the heart of Central, the HSBC Main Building marked its 40th anniversary yesterday evening — a milestone that brings both nostalgia and admiration. Designed by Lord Norman Foster, this fourth-generation headquarters redefined what a “future office” could be when it opened four decades ago, with its bold structure, open façades, open-plan spaces and early adoption of energy-efficient systems setting new standards for sustainable, intelligent architecture in Hong Kong. The celebration took place on the 20th floor — the very place where I began my career with HSBC 26 years ago. I still remember stepping into this remarkable building for the first time — nervous yet excited — surrounded by sunlight pouring through the giant glass curtain walls and bridges that connect one floor to another. It challenged every convention of a traditional bank office and showed me that a workplace could be functional, sustainable and inspiring at the same time. Back home later, I found an old photo of me and my colleagues taken on that same floor. Placing it beside a snapshot from this evening, it felt as if time had folded onto itself. The building — once a symbol of Hong Kong’s rise as a global financial centre — remains a living reflection of the city’s ongoing reinvention and resilience. A highlight of the evening was Lord Norman Foster’s presence in person, sharing the story behind his vision for this “inside-out” structure — how he wove together light, air, views, the surrounding city and even feng shui principles into a single, coherent design. His long relationship with Hong Kong, from the HSBC headquarters to the airport, West Kowloon and Kai Tak, has left a lasting imprint on our skyline and underlines Hong Kong’s role as a stage for world-class architecture and infrastructure. For me, this anniversary was both a tribute to an architectural icon and a salute to my first job in finance. The view from the 20th floor may have changed over time, but 1 Queen’s Road Central still stands firm — quietly witnessing the evolution of Hong Kong, and of our generation. (Link to a TVB programme from 1986 introducing the building is in the comments section) HSBC David Liao Maggie Ng Norman Foster Winnie Wing Yin Ho
Experience & Education
-
Deep Knowledge Group
******* *******
-
********* ****
******
-
*****************
******** *******
-
******** ******** ********** ** ********** ********** * ****
-
-
View Dmitry’s full experience
See their title, tenure and more.
Already on LinkedIn? Sign in
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
Publications
Languages
-
English
-
Organizations
-
BioGerontology Research Foundation
Trustee
- Present
View Dmitry’s full profile
-
See who you know in common
-
Get introduced
-
Contact Dmitry directly
Explore more posts
-
Sarah Turner
Angel Academe - increasing… • 10K followers
Calling all #healthtech investors! This #FemaleFounder pitch event in October, features 14 startups working in precision medicine, cancer diagnostics, cell therapy etc. All have previously received significant grant funding from SBRI Healthcare & NIHR (National Institute for Health and Care Research) Angel Academe - increasing female investment investors, THENA Capital Chantal Cox Robert Mollen Helen Jones Jo Pisani Rowena Ironside Yee Mun Thum
17
2 Comments -
Vishal Gulati
Dr Vishal Gulati, is a… • 11K followers
Long overdue change. Hosptial data and primary care data tell different parts of a patient’s story. We need both. How does primary care data help? Better case capture Includes conditions mainly managed in primary care. Dementia, type 2 diabetes, mental health, and long-term conditions often never appear in hospital datasets. Stronger longitudinal coverage Closes gaps between hospital episodes. Tracks diagnoses, referrals, and prescriptions over time. Clearer multimorbidity insight Lets you study how diseases co-occur and interact. Supports analysis of complex comorbidity patterns. Greater statistical precision Larger case counts increase power. Risk estimates tighten, with narrower confidence intervals. Earlier disease definition GP records flag conditions months or years before hospital admission. Improves early phenotyping. True treatment behaviour Prescription records show what patients actually take. Goes beyond hospital discharge medication lists.
13
1 Comment -
Alan Murray
Conceivable Life Sciences • 7K followers
Last year Conceivable Life Sciences premiered a short film called 𝘛𝘩𝘦 𝘐𝘯 𝘝𝘪𝘵𝘳𝘰 𝘗𝘰𝘴𝘴𝘪𝘣𝘭𝘦 (see link to film in comments) that was inspired by complex systems thinker and MacArthur Genius Stuart Kauffman's theory: The Adjacent Possible. In the film we showed how Conceivable "stole" technology from areas like chip manufacturing, ophthalmology, and autonomous driving to reimagine the IVF lab as an AI-powered automated system and how it is going to pioneer improvements in IVF outcomes and access. Turns out we're not the only ones to be inspired by Kauffman. OK Go, the band known for its inventive videos, catchy melodies, and positive energy, just released a new album called: "And The Adjacent Possible." Since the album's debut video heavily features robotics, was shot on an iPhone (which "The In Vitro Possible" uses as a prime example of combining technology to create something wholly new), and got props from Tim Cook—"𝙊𝙆 𝙂𝙤 𝙠𝙣𝙤𝙬𝙨 𝙝𝙤𝙬 𝙩𝙤 𝙢𝙖𝙠𝙚 𝙖𝙣 𝙞𝙣𝙘𝙧𝙚𝙙𝙞𝙗𝙡𝙚 𝙢𝙪𝙨𝙞𝙘 𝙫𝙞𝙙𝙚𝙤!"—we decided to do a little mash-up with Ok Go and our automated IVF lab AURA. Enjoy.
87
6 Comments -
Jonathan Tobin
Brandon Capital • 10K followers
This is a thorough, timely and well-written report on UK university-investor links by Tony Hickson at Cancer Research Horizons; and thank you for specifically mentioning Brandon Capital in the context of the BioCatalyst collaboration we operate across >50 medical research institutes across Australasia. This model has given us unrivalled visibility and access to early-stage ideas, and created collaborations and transparency across the ecosystem. Three points jumped out at me in Tony's report: 1) UK universities produce large numbers (hundreds) of companies, but very few (5%) ever raise significant money (>£100m). Quality always trumps quantity in company creation. 2) Historically, a relative shortage of sector-specific and unconstrained (pre)seed-stage investors that can deploy meaningful amounts of cash (>£5m) very early - crucial for creating new companies that have "legs". 3) >70% of large and late-stage venture funding (>£100m) is coming from non-UK funds. There are pros and cons to this - it shows the UK sector is robust, resilient and globally attractive, but also that much of the economic benefit is ultimately exported, and UK funds are shouldering too much early risk (certainly in biotech where significant up-rounds are rare, therefore only investing early without the means to follow-on is not economically rewarded). https://lnkd.in/ei-KgbwP
84
2 Comments -
Jesse Heasman
Soapbox • 5K followers
Venture funding rewind ⏪ Last week £116m in VC funding was announced for UK start-ups. Highlights from the Soapbox platform 💻 and newsletter 📩 include... 📌 Engitix Therapeutics raised a £20m Series A extension to develop therapies for cancer and fibrosis 📌 Biographica announced £7m in funding led by Faber to accelerate the creation of climate-resilient crop varieties 📌 MAIA Technology Limited secured £4m Series A from Molten Ventures to deliver modern portfolio management to hedge funds 📌 AgileRL landed a £6m seed round led by Fusion Fund to speed up reinforcement learning for training AI models 📌 And iMaintain raised over £250k in pre-seed funding from SFC Capital to build a maintenance knowledge platform for manufacturers
42
3 Comments -
Nisa Leung
Aulis Capital • 15K followers
One of the most inspiring shifts in gene therapy isn’t happening in the lab—it’s happening in clinic workflow. U.K. biotech Ikarovec signed an exclusive worldwide option with VectorBuilder to pair a novel AAV capsid with IKAR-003 for intermediate AMD, targeting intravitreal delivery designed for the doctor’s office (not the OR). If that sounds “operational,” it’s because scale is operational. Intermediate AMD affects millions and still has no approved drug treatments; preventing progression will require a delivery model that matches real-world capacity, training, and access. Reality check: IKAR-003 remains preclinical, and macula-wide transduction claims are based on non-human primate data. Durability, safety, and immunogenicity will ultimately decide whether this translates. The teams that win here will treat delivery, evidence, and trust as one system—building the procedure pathway, reimbursement logic, and follow-up infrastructure in parallel with the clinical package. #GeneTherapy #Ophthalmology #Biotech #DrugDelivery https://lnkd.in/gmAQb3xM
47
1 Comment -
Lloyd Price
Nelson Advisors • 12K followers
Mayo Clinic ramps up spinout creation as funding cuts bite US university hospital system Mayo Clinic, known for its pioneering healthcare research, is homing in on creating and funding companies based on its own healthcare IP, as government funding for health research wanes in the US under the Trump administration. “Mayo is at a time of tight capital markets and increased scrutiny from an [National Institutes of Health] funding perspective and a flight to quality in the capital markets. So, Mayo is really doubling down and standing behind its #innovative #technology,” says Audrey Greenberg, a venture partner hired under new programme aimed at boosting venture building. The Mayo Clinic launched the programme in May to bring in external #entrepreneurs and experienced #investors who could build companies based #intellectualproperty from the Mayo Clinic. The initiative builds on the role of #MayoClinicVentures, the commercialisation arm of the #MayoClinic which licenses and creates ventures based on the #medical centre’s #IP. https://lnkd.in/dbdMNZT3
5
-
Katie Lockwood
Twin Path Ventures • 5K followers
What a woman! Having now worked on nearly 10 university spin out deals at Twin Path Ventures, I can tell you it is not an easy thing to accomplish. The fact this was a joint spin out from two world leading universities speaks volumes of the brilliance of Maria Leiloglou who has gone on to assemble a world class team building software only hyperspectral imaging for surgery.
38
1 Comment -
Chenyang Xu
8K followers
100,000 human imaging scans. 30 petabytes. 11 years. UK Biobank just completed the world’s largest human imaging study – but its true power lies in what comes next. With longitudinal scans tracking organ aging across decades, scientists are not just collecting data but are building a time machine for disease prevention.
128
5 Comments -
Kurt Buseck
Rex Capital LLC • 3K followers
The UK’s Isambard-AI supercomputer, a £225M project, is designed to accelerate breakthroughs in healthcare and agriculture, from earlier cancer detection to monitoring livestock health. What’s powerful here is the broader lesson: disruption comes when innovation is applied to industries where the stakes are high and the systems are complex. Infrastructure like this not only advances research but also empowers smaller players to plug in and benefit from national-level capabilities. At Rex, we’re interested in both ends of that spectrum — backing the foundational technologies that enable innovation, as well as the companies applying them to solve real-world problems. Sometimes that’s AI-powered diagnostics, and sometimes it’s a simpler technology that transforms waste into value. 📣 If your company is innovating in a way that could reshape your industry — whether deep tech or not — we want to hear your story. https://lnkd.in/e8nDEWnS
1
-
Daniela Deflorio
Digital DADAL • 10K followers
🔥 🌍 𝗬𝗼𝘂𝗿 𝗻𝗲𝘅𝘁 𝗯𝗶𝗴 𝗰𝗮𝗿𝗲𝗲𝗿 𝗹𝗲𝗮𝗽 𝗺𝗶𝗴𝗵𝘁 𝗻𝗼𝘁 𝗯𝗲 𝗶𝗻 𝗮 𝗵𝗼𝘀𝗽𝗶𝘁𝗮𝗹 𝗼𝗿 𝗹𝗮𝗯 𝗯𝘂𝘁 𝗶𝗻 𝗮𝗻 𝗔𝗜-𝗽𝗼𝘄𝗲𝗿𝗲𝗱 𝗵𝗲𝗮𝗹𝘁𝗵 𝘀𝘁𝗮𝗿𝘁𝘂𝗽. In this new decade of AI-driven healthcare, the most valuable professionals will be those who can connect disciplines, blending clinical knowledge with data, design, and regulatory insight. It’s no longer “AI vs. humans” it’s humans who can speak AI. If you’re planning your next career move, look for roles that stretch one of these three muscles: 1️⃣ Clinical or domain expertise 2️⃣ Data and product fluency 3️⃣ Regulatory or evidence-based thinking 𝗧𝗵𝗲𝘀𝗲 𝗿𝗼𝗹𝗲𝘀 𝘀𝗵𝗼𝘄 𝘄𝗵𝗲𝗿𝗲 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝗵𝗲𝗮𝗱𝗶𝗻𝗴. 👇 Here’s a great list shared by Dr. Vishaal Virani, MBBS: all current #HealthTech opportunities worth exploring #Healthtech #DigitalHealth #AIinHealthcare #CareerGrowth #ClinicalInnovation #RegulatoryAffairs #DigitalTransformation
8
1 Comment -
Renata Merino
Blazin Babes Capital • 5K followers
“Diagnostics” is one of the fastest growing sectors in health tech with the fastest exits in any venture fund or angel investment. Our fund conducted rigorous investment-grade research over the last 3 years under the health tech sector utilizing multiple research sources from various viewpoints (pharma, PitchBook, Statista, medical reports, Boston Consulting Group (BCG), McKinsey & Company and proprietary reports our firm purchased as part of our private investment in our fund ). We saw and identified sub-sectors within “Health tech” that not only have profound proactive health impact for both individuals but also for the overall global healthcare economy. “Diagnostics” was one of those identified lucrative investment sectors that our fund and firm identified in our 3 year research. Going forward, our fund continues to stay on top of healthcare early stage innovation emphasizing both impact and financial returns.
5
-
Leah Eliz Morris
Pillar VC • 5K followers
We're excited to share that the The UK’s Department for Science, Innovation and Technology intends to fund an expansion of Pillar VC's Encode: AI for Science Fellowship – announced by SoS Peter Kyle at #LDNTechWeek. Conceived and delivered by Pillar and enabled by Advanced Research + Invention Agency (ARIA), our programme embeds world-class AI researchers into cutting-edge scientific labs, accelerating the pathway to industry, and enabling talent to spend one year immersed in intensive exploration, feedback, and development cycles. The programme will be backed by the UK Sovereign AI Unit with up to £5m in Government funding. Encode Fellows will start in the UK in Autumn 2025. Read the full announcement: https://lnkd.in/gHMYMQ5s Keep up with Pillar VC Encode: AI for Science news: https://lnkd.in/g2TJUh55
164
11 Comments -
Anna M. Detert
4K followers
I’m delighted to share Gloucester Ventures' latest thought leadership, Part II in the three-part series, “The Future of Precision Diagnostics". In Part I, we showed how AI/ ML has enabled innovations in detecting disease with greater sensitivity and specificity. In Part II, we predict how generative and agentic AI will unlock the next wave of precision diagnostics opportunities. We start with the diagnostics problem statement – five key challenges – such as limited data access and usability, proliferation of tests and less attractive revenue models. We then turn to the challenges into five ‘Must Have’s’ that AI can enable: - Ready to use, valued quality data via independent data exchanges - Regulation focused on quality of AI in clinical diagnostics - Harmonized precision diagnostics platforms vs. tests - Predictive Dx decisioning, powered by genAI, populated by agents - Evolved business models more akin to AI-native companies And finally we outline what this means for investors - with five potential bets in and around precision diagnostics. Many thanks to all of the superb contributors to this article: Tzvika Barkai, Reena Bhargava, MD, FACP Burns C. Blaxall, PhD, Ed Esplin, MD, PhD, FACMG, CGAF, FACP, Mark Hughes, Monica Isgut, PhD . Christopher Kan Dimitri Krylov, PhD, Jeffrey Edward Miller, Ph.D., Mika Newton, Dhruvajyoti Roy, Ph.D. ,Alexander Sicular, Karthik Suresh, and also to Robyn Baker for her excellent design work. The slides from the article are below; for the full article viewing, visit our website https://lnkd.in/eVBhEFEm media. Look forward to continuing the dialogue! #Gloucester Ventures #Precision Diagnostics #AI in diagnostics #AI in Healthcare
20
4 Comments -
Büşra Yılmaz
6K followers
🚀 New DOMiNO Ventures piece on the board: Antiverse. Antiverse is building an AI-native platform for antibody discovery, turning what used to be slow and manual into faster, smarter, and scalable processes. We’re excited to join the $9.3M Series A alongside Soulmates Ventures, Cardiff Capital Region, Development Bank of Wales, Kadmos Capital Ltd, i&i Biotech Fund, Innospark Ventures, and Totipotent Capital. Congrats to Murat Tunaboylu, Ben H., and the team 👏 Can’t wait to see what comes next. 🔗 https://www.antiverse.io/
55
-
Ben Cobb
ReadyGo • 2K followers
Why Migrant Entrepreneurs Are Vital to the UK’s Economic Success Across the UK’s startup ecosystem, migrant founders punch well above their weight. While people born overseas make up roughly 15% of the UK population, their impact on high-growth business creation is disproportionately large. 54% of the UK’s fastest-growing startups have at least one foreign-born founder, a figure far higher than the share of migrants in the population (https://lnkd.in/e3EGNM6h) Historically reports showed that 39% of the top 100 fastest-growing firms were founded or co-founded by migrant entrepreneurs (https://lnkd.in/eTj_ACu8) UK entrepreneurship surveys (like the Global Entrepreneurship Monitor) consistently find that immigrant and ethnic minority populations are among the most entrepreneurial groups in the country (https://lnkd.in/eusypDAK). What this means? • Migrant founders drive innovation, job creation, and international competitiveness. This grows even more in the second generations. • Their international networks and diverse experiences help them identify opportunities and scale businesses. • These contributions are crucial at a time when the UK is navigating post-Brexit immigration policy shifts and global talent competition. Why it matters? Building a thriving ecosystem requires welcoming talent from around the world not just because it’s ethically right, but because it’s an economically smart thing to encourage. The data shows that migrant entrepreneurs are central to the UK’s growth story.
36
4 Comments -
Pierre Socha
Amadeus Capital Partners • 25K followers
This is a profound step-change for #prostatecancer detection and management. The UK NHS is deploying Quibim QP-Prostate across key hospitals to make MRI the new standard for the early diagnosis of prostate cancer. Quibim is a global leader in virtual biopsies. Patients in the UK will soon have access to their MRI-based test that autonomously localizes tumors, stages them and more importantly flags high virulence cases. All of it in a non-invasive and painless way. No more unnecessary biopsies. More aggressive cancers will be detected earlier. More lives will be saved.
22
2 Comments
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Dmitry Kaminskiy
3 others named Dmitry Kaminskiy are on LinkedIn
See others named Dmitry Kaminskiy